New tool measures strengths of bonds that keep blood clots from washing away

August 19, 2010

( -- New work from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston shows that the bonds that hold wound-healing platelets in place have a special kind of stickiness that keeps them from being swept away in a rush of pulsing blood.

The lab of Timothy Springer, Latham Family Professor of Pathology at Harvard Medical School, found that bind to arterial walls using a unique double-acting bond that Springer calls a "flex-bond." A little like a kitchen cabinet with a child-safe latch, the bond holds in one mode at low forces, and in a different mode at higher forces. The work opens up the potential for a new understanding of bleeding diseases, such as von Willebrand disease, in which the genes that form platelet bonds have clot-preventing mutations. The work appears in the August 9 issue of Nature.

The body mends scratches and gashes by plugging holes in small with platelets. Platelets, which flow in the , stick together and to the walls of blood vessels to form a patch. "They need to bind to one another and they need to resist the force of blood pushing against them," says Springer.

To form the bonds that hold clots together, two proteins interact: One on the platelet surface, called glycoprotein Ib alpha (GPIb-alpha); and the other, called von Willebrand factor (VWF), which binds both to GPIb-alpha on platelets and to collagen in . VWF protein is mutated in von Willebrand disease. "This receptor-ligand pair needs to resist a lot of force," says Springer. "So we had a hunch that there might be something special about it."

To explore this hunch, Springer's team employed a novel technique, dubbed ReaLiSM (Receptor and Ligand in a Single Molecule). The technique involves the use of a single molecule that links the protein pair together, separately from the pair's normal bond, to measure how force affects the bond's strength.

The researchers first bind the proteins together as the pair would bind in a clot. Then they attach a flexible molecular chain to the ends of the proteins not involved in the biologically meaningful binding. They mimic the force of blood flow on the protein-protein bond by tugging apart the pair using laser-guided, molecular "tweezers" developed by a research team from the University of California, Berkeley. This tugging applies a force similar to that of a fluid threatening to wash away a bound platelet. The change in extension of the flexible chain measures the strength and lifespan of the bond.

"At low force, it was easy to break the bond," says Springer, the same way it is easy to break the magnetic bond holding a cabinet door shut. "But then, as we applied more force, the second state of this bond got engaged." Like a child safety latch, this second bond kicks in at higher forces and lasts longer than the first. Unlike other well-known bonds, such as slip bonds, which weaken with force, and catch bonds, which strengthen with force, "this receptor-ligand pair is really specialized to resist a broad range of forces."

The discovery sheds light on the physics underlying the process of wound-healing. "Anytime you have a better understanding of biophysics, you can treat patients and treat diseases better," says Springer.

Springer's lab will follow up on this work by exploring how this bond behaves in patients with von Willebrand disease. By using his new measurement technique to test clinical samples that contain mutated forms of the two proteins, Springer hopes to better understand how these mutations give rise to bleeding disorders.

The work also opens the door to examining other receptor-ligand pairs in the body to see how they react to force. "There are forces everywhere in the body. In the intestine, in muscles and tendons, in the skin, there are many, many adhesion molecules that keep your body together that have to resist force."

More information: "A Mechanically Stabilized Receptor-Ligand Flex-Bond Important in the Vasculature" Jongseong Kim, Cheng-Zhong Zhang, Xiaohui Zhang and Timothy A. Springer.

Related Stories

Recommended for you

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Study confirms link between the number of older brothers and increased odds of being homosexual

December 12, 2017
Groundbreaking research led by a team from Brock University has further confirmed that sexual orientation for men is likely determined in the womb.

Potassium is critical to circadian rhythms in human red blood cells

December 12, 2017
An innovative new study from the University of Surrey and Cambridge's MRC Laboratory of Molecular Biology, published in the prestigious journal Nature Communications, has uncovered the secrets of the circadian rhythms in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.